文献速递临床试验与 GCP

数字交付的失眠认知行为疗法(CBT-I)用于慢性疼痛合并失眠患者(Back2Sleep试验):随机对照试验研究方案

Digitally delivered cognitive behavioral therapy for insomnia (CBT-I) for patients with chronic pain and insomnia (The Back2Sleep Trial): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2025-08-15

Back2Sleep试验为1:1随机、单盲、优效性试验,纳入160例致残性慢性疼痛合并失眠患者,比较9周应用程序交付的CBT-I与应用程序交付的睡眠卫生教育(主动对照)。主要结局为干预前后失眠严重指数(ISI)和平均疼痛强度(0-10数字评定量表)的组间变化差异,并评估短期、中期和长期次要结局及家庭耳脑电图睡眠指标。

要点

  • 超过半数慢性疼痛患者合并失眠,CBT-I为有效安全的一线治疗但可及性差。
  • 试验比较9周应用程序交付CBT-I与睡眠卫生教育对失眠和疼痛严重程度的影响。
  • 主要结局为ISI和平均疼痛强度从基线至干预后的组间变化差异。

核心结论

  • 该研究方案旨在评估9周应用程序交付的CBT-I相比应用程序交付的睡眠卫生教育,在减轻致残性慢性疼痛合并失眠患者的失眠和疼痛严重程度方面的有效性。

研究设计与样本

  • 1:1随机、单盲、优效性试验,随机分配160例致残性慢性疼痛合并失眠患者至9周应用程序交付的CBT-I组或9周应用程序交付的睡眠卫生教育组。

主要发现

  • 主要结局为失眠严重指数(ISI)和平均疼痛强度(0-10数字评定量表)从基线至干预后的组间变化差异。
  • 短期次要结局包括睡眠和疼痛的感知效果(全局感知效果量表)、睡眠质量、对睡眠和疼痛的想法与信念、躯体和心理健康以及EQ5D-5L。
  • 中期和长期次要结局(ISI、疼痛强度、EQ5D-5L、医疗费用以及睡眠和疼痛药物使用)将在24周和52周后收集。
  • 探索性生理睡眠指标将通过家庭耳脑电图(EEG)在基线和第8周各采集5晚。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: More than half of individuals with chronic pain also experience insomnia. Cognitive behavioral therapy for insomnia (CBT-I) is an effective and safe first-line treatment; however, access remains a major barrier to widespread implementation. This study aims to evaluate the effectiveness of a 9-week app-delivered CBT-I intervention, compared to an app-delivered sleep hygiene education program (active control), in reducing insomnia and pain severity in patients with disabling chronic pain and comorbid insomnia. METHODS: The trial is a 1:1 randomized, single-blind, superiority trial randomizing 160 patients with disabling chronic pain and comorbid insomnia to either app-delivered CBT-I for 9 weeks or app-delivered sleep hygiene education for 9 weeks. Primary outcomes are the between-group differences in change in Insomnia Severity Index (ISI) and average pain intensity assessed using a 0-10 numeric rating scale (NRS) from baseline to post-interventions. Short-term secondary outcomes post-intervention include perceived effects on sleep and pain (Global Perceived Effect scales), sleep quality, thoughts and beliefs about sleep and pain, physical and mental health, and EQ5D-5L. Medium-term and long-term secondary outcomes (ISI, pain intensity, EQ5D-5L, health care costs, and use of sleep and pain medication) will be collected after 24 and 52 weeks. Exploratory physiological sleep metrics from at-home ear-electroencephalography (EEG) will be collected for five nights at baseline and for five nights during week 8. DISCUSSION: This planned study addresses a critical need for identifying effective, safe, and easily accessible alternatives to the current treatments for patients with chronic pain and insomnia. TRIAL REGISTRATION: ClinicalTrials.gov NCT06361914. Registered on April 17, 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Olsen MLS, Thorlund JB, Zachariae R, et al. Digitally delivered cognitive behavioral therapy for insomnia (CBT-I) for patients with chronic pain and insomnia (The Back2Sleep Trial): study protocol for a randomized controlled trial. Trials. 2025. PMID: 40817235. doi:10.1186/s13063-025-09013-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。